|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 471/04 | (2006.01) |
| A61K 31/4738 | (2006.01) | ||
| A61K 31/497 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3433256 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17783857.0 |
| Date of filing the European patent application | 2017-10-13 | |
| (97) | Date of publication of the European application | 2019-01-30 |
| (45) | Date of publication and mention of the grant of the patent | 2019-08-07 |
| (46) | Date of publication of the claims translation | 2019-11-11 |
| (86) | Number | PCT/EP2017/076191 |
| Date | 2017-10-13 |
| (87) | Number | WO 2018/077630 |
| Date | 2018-05-03 |
| (30) | Number | Date | Country code |
| 201662411799 P | 2016-10-24 | US | |
| 201662435159 P | 2016-12-16 | US |
| (72) |
SCOTT, James, Stewart, GB
BARLAAM, Bernard, Christophe, GB
YANG, Bin, US
MOSS, Thomas, Andrew, GB
HUGHES, Samantha, Jayne, GB
NISSINK, Johannes, Wilhelmus, Maria, GB
O`DONOVAN, Daniel, Hillebrand, GB
|
| (73) |
Astrazeneca AB,
151 85 Södertälje,
SE
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | 6,7,8,9-Tetrahidro-3H-pirazolo[4,3-f]izochinolino darinys, naudingas vėžio gydymui |
| 6,7,8,9-TETRAHYDRO-3H-PYRAZOLO[4,3-F]ISOQUINOLINE DERIVATIVE USEFUL IN THE TREATMENT OF CANCER |
| Payment date | Validity (years) | Amount | |
| 2025-09-23 | 9 | 208.00 EUR |
| 2026-10-13 |